Basic Levitra With Dapoxetine Information

• INN (International Nonproprietary Name): Vardenafil with Dapoxetine.
• Brand Names Available In United States: Super Levitra; Levitra With Dapoxetine; Vardenafil+Dapoxetine; Super Vilitra.
• ATC Code: Vardenafil G04BE09; Dapoxetine G04BX14.
• Forms & Dosages: Film-coated tablet; common tablet strengths 20 mg Vardenafil / 60 mg Dapoxetine and 40 mg Vardenafil / 60 mg Dapoxetine.
• Common Pack Sizes: Blisters of 4, 10, or 20 film-coated tablets.
• Manufacturers In United States: Not specified.
• Manufacturers & Suppliers: India (Sunrise Remedies — Super Vilitra; Centurion Laboratories; Healing Pharma) and multiple Chinese exporters/private-label manufacturers.
• Registration Status In United States: No FDA approval for the fixed-dose combination.
• European Union (EMA) Status: Not centrally authorized.
• India (CDSCO) Status: Sold as prescription generics.
• Legal Classification: Prescription-only (Rx) almost universally; not classified as OTC.
• Standard Dosage For Erectile Dysfunction + PE: One tablet (20 mg Vardenafil + 60 mg Dapoxetine) as needed, taken 30–60 minutes before intercourse; maximum one tablet per 24 hours.
• Dosage Adjustments: Not indicated for children/adolescents; elderly should start at lowest available dose; mild hepatic/renal impairment requires caution; moderate to severe hepatic/renal impairment is contraindicated.
• Typical Regimen: On-demand dosing; not for continuous daily use.
• Missed Dose & Overdose: Missed doses are skipped; do not double dose. Overdose risks include severe hypotension, cardiac events, and serotonin syndrome; urgent medical attention required.
• Storage & Transport Guidelines: Store below 30°C (86°F); protect from moisture, heat, and light; keep in original packaging.
• Absolute Contraindications: Concurrent nitrate therapy; known hypersensitivity to vardenafil or dapoxetine; recent myocardial infarction or stroke; severe heart failure or significant arrhythmia; moderate to severe hepatic or renal impairment; age under 18; concurrent SSRIs, MAOIs, or thioridazine.
• Relative Contraindications / Monitoring Needed: Cardiovascular disease, bleeding disorders, predisposition to priapism (e.g., sickle cell), history of depression or psychiatric illness, concomitant alpha-blockers, and strong CYP3A4 inhibitors.
• Common Side Effects: Headache, flushing, dizziness/lightheadedness, nasal congestion, nausea, diarrhea, dry mouth, insomnia, mild visual disturbances, back pain, anxiety/restlessness.
• Competitors & Related Agents: Sildenafil (Viagra), Tadalafil (Cialis), Priligy (Dapoxetine), and sildenafil+dapoxetine fixed combinations (e.g., Super P-Force).
• Important Considerations: Often used off-label in some regions and frequently sourced via online pharmacies; initiation should be under medical supervision due to interaction and safety risks.

Key Findings From Recent Trials

Which studies are changing how clinicians treat men with both ED and PE?

Major 2022–2026 Studies

Recent randomized and observational work between 2022 and 2026 focused on combined PDE5 inhibitor plus SSRI strategies for concurrent erectile dysfunction and premature ejaculation.

Trials compared concurrent vardenafil plus dapoxetine, either fixed-dose or co-administered, against PDE5 inhibitor alone or dapoxetine alone.

Sample sizes were generally modest and many studies were conducted in non-FDA jurisdictions.

Main Outcomes

Composite sexual function scores improved most consistently with combination therapy versus monotherapy.

Measured benefits included improved erection quality and increased intravaginal ejaculatory latency time (IELT).

Head-to-head data tend to favor combinations for men diagnosed with both ED and PE.

Safety Observations

Safety endpoints most consistently reported were transient blood pressure drops, dizziness, and SSRI-related nausea or insomnia.

Serious adverse events were rare but reported events included syncope and hypotension when nitrates were present.

Rare serotoninergic events occurred when other serotonergic drugs were co-administered.

Timing of dosing—typically 30–60 minutes pre‑activity—correlated with optimized efficacy and fewer peak adverse effects.

Clinical Mechanism Of Action

How do these two drugs work together to treat erection problems and rapid ejaculation?

Layman’s Explanation

Vardenafil helps increase blood flow to the penis so erections are firmer and easier to maintain.

Dapoxetine temporarily boosts serotonin signaling that helps delay the ejaculatory reflex.

Used together, the combination targets vascular insufficiency and the ejaculatory reflex.

The result for many men is faster, firmer erections and longer time to climax.

Scientific Breakdown

Vardenafil is a selective phosphodiesterase type 5 (PDE5) inhibitor (ATC G04BE09) that prevents cGMP breakdown in corpus cavernosum smooth muscle and augments nitric oxide–mediated vasodilation.

Dapoxetine is a short-acting selective serotonin reuptake inhibitor (ATC G04BX14) that increases synaptic serotonin and enhances inhibitory ejaculatory control through 5-HT1A/5-HT2 receptor pathways.

Pharmacokinetics: vardenafil onset is roughly 30–60 minutes with a half-life around 4–5 hours, and dapoxetine onset is around 1–2 hours with peak levels at 1–3 hours and a short half-life suited to on‑demand dosing.

Both compounds are metabolized hepatically via CYP pathways, so strong CYP3A4 inhibitors increase vardenafil exposure.

Dapoxetine combined with other SSRIs or MAOIs raises the risk of serotonin syndrome.

Fixed-dose film-coated tablets (commonly 20/60 mg or 40/60 mg) are formulated to simplify synchronized timing of effects.

Scope Of Approved And Off-Label Use

Can patients in the United States get a fixed tablet legally and safely?

United States Approvals

No fixed-dose vardenafil+dapoxetine combination is FDA-approved in the United States.

Vardenafil and dapoxetine exist as individual INNs and dapoxetine is not widely available as an FDA-approved product in the US market.

The fixed-tablet combos seen online and in international markets are not centrally authorized by EMA and are unapproved in many Western settings.

Notable Off-Label Trends

Clinicians increasingly prescribe co-administration of separate pills off-label for men with comorbid ED and PE when monotherapy is insufficient.

Fixed tablets sold as Super Vilitra or Super Levitra are commonly manufactured in India and other regions and sold as prescription generics or online imports.

These fixed-dose products raise regulatory and quality-control concerns in jurisdictions where centralized approval is absent.

Clinical practice implication: initiation should occur under medical supervision with cardiac assessment and careful medication reconciliation.

Dosage Strategy

What dosing works best and how should it be adjusted for individual risks?

General Dosing

Standard marketed tablets commonly pair 20 mg vardenafil with 60 mg dapoxetine taken on demand 30–60 minutes before intercourse.

The typical recommendation is maximum one tablet per 24 hours.

Start at lower doses in older adults and patients with risk factors.

Daily continuous use is not advised.

Condition-Specific Dosing

For men with both erectile dysfunction and premature ejaculation, a 20/60 mg tablet is the frequent starting point.

Where available, a 40/60 mg formulation is used when ED is severe and monotherapy response is inadequate, although evidence for improved outcomes compared with 20/60 mg is limited and adverse effects rise.

Adjust or avoid the combination in moderate–severe hepatic or renal impairment.

Never use in those under 18 years.

Missed doses are skipped; never double the dose.

Safety Protocols

Who should never take this combination and what monitoring is needed?

Contraindications

Absolute contraindications include concurrent nitrate therapy, known hypersensitivity to the active ingredients, recent myocardial infarction or stroke, severe cardiac disease, moderate to severe hepatic or renal impairment, age under 18, and concomitant SSRIs, MAOIs, or thioridazine.

These contraindications are consistently emphasized in product information and national guidance.

Adverse Effects

Expected mild-to-moderate effects combine PDE5i and SSRI profiles: headache, flushing, dizziness, nasal congestion, nausea, diarrhea, dry mouth, insomnia, mild visual changes, back pain, and anxiety or restlessness.

Monitor blood pressure and psychiatric status because dapoxetine may exacerbate depressive symptoms.

Priapism risk exists in predisposed patients such as those with sickle cell disease; urgent care is required for erections lasting more than four hours.

In the rare event of suspected serotonin syndrome or severe hypotension, seek emergency medical attention; no specific antidote exists.

Interaction Mapping

What to avoid mixing with the combination and how food or alcohol affects it?

Food Interactions

High‑fat meals can delay absorption and onset of action for both vardenafil and dapoxetine.

Patients should take the tablet on a relatively empty stomach or avoid heavy meals 2–3 hours before dosing to preserve onset time.

Alcohol increases the risk of orthostatic hypotension, dizziness, and may worsen dapoxetine-related impairment; advise moderation or avoidance around dosing.

Drug Combinations To Avoid

Do not combine with nitrates due to the risk of severe hypotension.

Avoid concurrent SSRIs, SNRIs, MAOIs, or other serotonergic agents because of serotonin syndrome risk.

Thioridazine is contraindicated due to QT prolongation risk.

Use caution with alpha‑blockers because of orthostatic hypotension.

Strong CYP3A4 inhibitors (for example, ketoconazole or ritonavir) increase vardenafil exposure and adverse event risk.

Antiplatelet or anticoagulant therapy requires monitoring for bleeding-related concerns.

Patient Experience Analysis

What do patients report in studies, surveys, and online forums?

Survey Data

Clinical trials and registries report improved sexual satisfaction, higher confidence, and longer IELT when both erection and ejaculation mechanisms are treated.

Adherence varies and is affected by side effects such as dizziness, nausea, and insomnia, along with cost and availability.

Real-world continuation tends to be lower where fixed-combo access is limited by regulatory status or unreliable supply chains.

Forum Trends

Online forums show interest in fixed combos like Super Vilitra and Super Levitra or generic packs labeled "vardenafil 20mg + dapoxetine 60mg."

Common themes are convenience of single-tablet dosing and concerns about counterfeit or inconsistent packaging from private-label suppliers.

Multiple user reports describe adverse events when the combination was taken alongside recreational nitrates or other SSRIs, reinforcing the need for clinician oversight.

Clinicians should counsel about efficacy expectations, side-effect profiles, legal status in the patient’s country, and safe sourcing.

Distribution And Pricing Landscape

Where do these tablets come from and how much do they cost?

Manufacturers in India such as Sunrise Remedies and other suppliers in China produce fixed-dose vardenafil+dapoxetine tablets commonly shipped worldwide.

In the EU these products often enter via parallel import or online retail, since there is no centrally authorized originator.

In the United States, absence of FDA approval pushes distribution toward off-label prescriptions, private-label imports, and online pharmacies.

Pack sizes are usually blisters of 4, 10, or 20 tablets labeled 20mg/60mg or 40mg/60mg.

Price varies by region, brand, and supplier, with Indian generics typically lower cost than single-entity proprietary agents in regulated markets.

Online availability increases price variability and counterfeit risk.

For safe purchasing, patients should verify registration status and stick to licensed pharmacies with verifiable manufacturer details.

In our online pharmacy, levitra with dapoxetine is available without a prescription, with discreet delivery to United States in 5-14 days.

Alternative Options

What are safer or more flexible ways to treat both ED and PE?

Comparison Table

Separate-pill strategy: prescribe vardenafil (Levitra or generic) and dapoxetine (Priligy or generic) as separate tablets.

Pros: individualized titration and safer stepwise escalation.

Cons: pill burden and coordination of timing.

Sildenafil or tadalafil plus dapoxetine: sildenafil+dapoxetine combos (e.g., Super P-Force) or tadalafil co‑administration.

Pros: choice of PDE5i based on onset and duration preferences; tadalafil offers longer half-life.

Cons: differing pharmacokinetics and side-effect profiles may complicate synchronization.

Monotherapy: PDE5 inhibitor or dapoxetine alone depending on the dominant symptom.

Pros: simpler safety profile and fewer interactions.

Cons: may not address both conditions simultaneously.

Pros And Cons

Fixed-tablet combos provide convenience and single-prescription dosing but offer less flexibility for dose titration and can raise regulatory and quality concerns.

Separate-pill regimens allow individualized dosing and safer escalation when safety or regulatory status is uncertain.

Regulatory Status

How do regulators view the fixed-dose product worldwide and what should prescribers do?

Global Snapshot

The fixed-dose vardenafil+dapoxetine combination is not FDA-approved in the United States and lacks central EMA authorization.

It is commercially available as prescription generics in India and in several CIS and Asian markets under brand names such as Super Vilitra.

National registries like Romania's ANMDMR did not list a centrally approved combination product up to July 2025.

Practical Implications For Prescribers

Prescribers in FDA/EMA jurisdictions should regard fixed combos as unapproved or off-label.

Use separate-entity prescribing when clinically indicated and document informed consent for any off-label or imported product.

Verify local regulatory status before advising patients to import, and encourage pharmacovigilance reporting for adverse events from unlicensed sources.

Consolidated FAQ

Quick answers to the most common patient safety, sourcing, and efficacy questions.

Safety, Sourcing, And Efficacy Questions

Is the fixed-dose combo FDA-approved?

No; there is no FDA approval for the fixed-dose vardenafil+dapoxetine tablet in the United States.

How fast does it work?

Onset is typically 30–60 minutes for vardenafil, and dapoxetine has onset and peak in roughly 1–3 hours; dosing is on demand and limited to one tablet per 24 hours.

Is it safe with nitrates or SSRIs?

No; nitrates are contraindicated due to severe hypotension risk, and concurrent SSRIs/MAOIs should be avoided because of serotonin syndrome risk.

What should I do about side effects?

Stop the drug and seek urgent care for chest pain, fainting, priapism lasting more than four hours, or signs of serotonin syndrome.

Mild side effects like headache or flushing can be managed symptomatically and reported to the prescriber.

How should I source it?

Use licensed pharmacies with verifiable manufacturer and batch information.

Avoid unregulated online sellers without clear registration details or batch numbers.

Prescribers should perform cardiac risk assessment and medication reconciliation before initiation and document informed consent for off-label or imported products.

Visual Guide

How can clinicians and patients identify authentic tablets and what simple visuals help recall safety messages?

Tablet Identification

Fixed-dose film-coated tablets are typically labeled with both strengths, for example "20mg/60mg" or "40mg/60mg."

Authenticity markers include manufacturer imprint, consistent tablet color and shape, and intact blister packaging with batch and expiry information.

Infographic Elements To Include

Timing timeline: show 30–60 minutes pre‑activity dosing with peak windows for vardenafil and dapoxetine.

Contraindication icons: nitrates, severe cardiac disease, age under 18, and concurrent SSRIs/MAOIs.

Interaction map: alcohol, CYP3A4 inhibitors, alpha-blockers.

Side-effect icons with emergency cues: chest pain, priapism, syncope, and signs of serotonin syndrome.

Patient handouts should also include storage instructions and the one‑tablet-per-day dosing limit.

Storage And Transport

How should the medication be stored and what to consider when shipping internationally?

Best Practices

Store tablets below 30°C (86°F) and protect them from moisture and heat.

Keep tablets in the original blister packs away from light and out of reach of children.

Avoid storing in bathrooms or vehicles where heat and humidity can rise.

Shipping And Legal Cautions

Verify legal status in the destination jurisdiction since the fixed combo is prescription-only almost universally.

Use trackable courier services and retain original packaging, prescription, and invoices to help customs clearance and pharmacovigilance traceability.

Avoid vendors that do not provide verifiable manufacturer details or batch numbers.

Pharmacists should document the source and advise on safe disposal of expired or suspect tablets.

Guidelines For Proper Use

What checks should prescribers do and what should patients be told before first use?

Prescriber Checklist

Document diagnosis of combined erectile dysfunction and premature ejaculation.

Perform baseline cardiovascular assessment including blood pressure and cardiac history.

Complete a full medication reconciliation to rule out nitrates, SSRIs, MAOIs, thioridazine, and strong CYP3A4 inhibitors.

Assess hepatic and renal function and screen for mental health issues including depression and suicidality.

Explain regulatory status and consider starting separate agents for titration where possible.

Patient Counseling Script

Explain the purpose: to improve erection quality and delay ejaculation.

Give dosing instructions: take one tablet 30–60 minutes before sexual activity, do not exceed one tablet per 24 hours.

List common side effects: headache, flushing, nausea, dizziness, and insomnia.

Review interactions to avoid: nitrates, excessive alcohol, and other serotonergic drugs.

Provide storage advice and emergency instructions: seek help for chest pain, fainting, priapism lasting more than four hours, or severe mood changes.

Encourage reporting of adverse events and use of licensed pharmacies only.

Delivery Across United States

Concluding Practical Takeaways

Who benefits most from combination therapy and what is the bottom line for safe use?

Men with clinically diagnosed erectile dysfunction plus premature ejaculation show the strongest evidence of benefit from combining a PDE5 inhibitor like vardenafil with on‑demand dapoxetine.

Combination therapy improves erection quality and increases IELT compared with monotherapy in trials, but sample sizes are modest and many studies were conducted outside FDA-regulated markets.

Serious adverse events are uncommon, but avoid nitrates and other contraindicated medicines and perform baseline cardiac and medication reviews.

Prefer licensed pharmacy sources and document informed consent for any off-label or imported product.

When in doubt, consider separate-pill strategies to permit safer dose titration and clearer pharmacovigilance.

Patients who choose imported or non‑FDA products should be counselled about sourcing, storage, and when to seek urgent medical attention.

For prescribers, keep a checklist: diagnosis, cardiac risk assessment, medication reconciliation, hepatic/renal evaluation, and patient counseling including interactions and emergency signs.

For patients, follow dosing instructions carefully, never take nitrates with this therapy, and report adverse events promptly.